Exact Mass: 324.200898

Exact Mass Matches: 324.200898

Found 87 metabolites which its exact mass value is equals to given mass value 324.200898, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Etonogestrel

Etonogestrel

C22H28O2 (324.2089188)


G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

Lactapiperanol D

10-Hydroxy-13-methoxy-3,6,6-trimethyl-12-oxatetracyclo[8.3.0.0¹,³.0⁴,⁸]tridecan-9-yl acetic acid

C18H28O5 (324.1936638)


Lactapiperanol B is found in mushrooms. Lactapiperanol B is a constituent of Lactarius piperatus.

   

Cibaric acid

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

C18H28O5 (324.1936638)


Cibaric acid is found in mushrooms. Cibaric acid is isolated from damaged fruit bodies of the edible chanterelle mushroom (Cantharellus cibarius). Isolated from damaged fruit bodies of the edible chanterelle mushroom (Cantharellus cibarius). Cibaric acid is found in mushrooms.

   

Etonogestrel

(1S,2R,10S,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxy-17-methylidenetetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C22H28O2 (324.2089188)


Etonogestrel is only found in individuals that have used or taken this drug. It is a molecule used in hormonal contraceptives, most notably the subdermal implant Implanon. [Wikipedia]Etonogestrel binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like etonogestrel will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03A - Hormonal contraceptives for systemic use > G03AC - Progestogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   
   
   
   

Marrulanic acid

(-)-Marrulanic acid

C18H28O5 (324.1936638)


   
   

Grindelistrictoic acid

Grindelistrictoic acid

C18H28O5 (324.1936638)


   
   
   
   

4-tert-Butylbenzo-15-crown-5

4-tert-Butylbenzo-15-crown-5

C18H28O5 (324.1936638)


   
   

1-Methoxy-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran

1-Methoxy-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran

C22H28O2 (324.2089188)


   
   

11-[3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid

11-[3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid

C18H28O5 (324.1936638)


   

3??-Acetoxy-4??-hydroxy-11(13)-eudesmen-12-oic acid methyl ester

3??-Acetoxy-4??-hydroxy-11(13)-eudesmen-12-oic acid methyl ester

C18H28O5 (324.1936638)


   

4-muurolen-7,15-diol, 15-malonate ester

4-muurolen-7,15-diol, 15-malonate ester

C18H28O5 (324.1936638)


   

1beta,10beta-epoxy-6beta-(2-semialdehyde acetal hydroxymethylacroyloxy)-8beta-ethoxyeremophil-7(11)-en-12,8alpha-olide

1beta,10beta-epoxy-6beta-(2-semialdehyde acetal hydroxymethylacroyloxy)-8beta-ethoxyeremophil-7(11)-en-12,8alpha-olide

C18H28O5 (324.1936638)


   

3-Hydroxy-6-isopropyl-3-methyl-9-(5-oxotetrahydrofuran-2-yl)-4,9-decadienoic acid

3-Hydroxy-6-isopropyl-3-methyl-9-(5-oxotetrahydrofuran-2-yl)-4,9-decadienoic acid

C18H28O5 (324.1936638)


   

benzoylfervanol|fervanol benzoate

benzoylfervanol|fervanol benzoate

C22H28O2 (324.2089188)


   

(4-nonylphenyl)benzoate

(4-nonylphenyl)benzoate

C22H28O2 (324.2089188)


   

8alpha-benzoyloxycaryophyllene

8alpha-benzoyloxycaryophyllene

C22H28O2 (324.2089188)


   

khusol benzoate|Khusolbenzoat

khusol benzoate|Khusolbenzoat

C22H28O2 (324.2089188)


   

15-Malonyl-4-Amorphene-11,15-diol

15-Malonyl-4-Amorphene-11,15-diol

C18H28O5 (324.1936638)


   
   

3??-Acetoxydiversifolol

3??-Acetoxydiversifolol

C18H28O5 (324.1936638)


   
   

10-epidihydrobotrydial

10-epidihydrobotrydial

C18H28O5 (324.1936638)


   

(2S)-1-[2,6-dimethoxy-4-(prop-2-enyl)phenoxy]-3-ethoxy-3-methylbutan-2-ol|lenisin C

(2S)-1-[2,6-dimethoxy-4-(prop-2-enyl)phenoxy]-3-ethoxy-3-methylbutan-2-ol|lenisin C

C18H28O5 (324.1936638)


   

khusinol benzoate|Khusinolbenzoat

khusinol benzoate|Khusinolbenzoat

C22H28O2 (324.2089188)


   
   

2-(8-hydroxy-2-oxotridecyl)-6-oxopyran-4-olate

2-(8-hydroxy-2-oxotridecyl)-6-oxopyran-4-olate

C18H28O5 (324.1936638)


   

CA6PE2

CA6PE2

C18H28O5 (324.1936638)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); The position of the carboxylic group was assigned arbitrarily; locations of branching points are undetermined; Digitised from figure: approximate intensities

   

9a-Fluoro-B-hydroxyandrosterone

9a-Fluoro-B-hydroxyandrosterone

C19H29FO3 (324.2100616)


   

4,7,10,13-Docosatetraynoic acid

4,7,10,13-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

5,8,11,14-Docosatetraynoic acid

5,8,11,14-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

7,10,13,16-Docosatetraynoic acid

7,10,13,16-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid

12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid

C18H28O5 (324.1936638)


   

Dinor-PGE2

2,3-dinor-9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid

C18H28O5 (324.1936638)


   

Dinor-PGD2

2,3-dinor-9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid

C18H28O5 (324.1936638)


   

Lactapiperanol D

10-hydroxy-13-methoxy-3,6,6-trimethyl-12-oxatetracyclo[8.3.0.0^{1,3}.0^{4,8}]tridecan-9-yl acetate

C18H28O5 (324.1936638)


   

Cibaric acid

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

C18H28O5 (324.1936638)


   

FA 22:8

7,10,13,16-Docosatetraynoic acid

C22H28O2 (324.2089188)


   

FA 18:4;O3

12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid

C18H28O5 (324.1936638)


   

abietic acid sodium salt

abietic acid sodium salt

C20H29NaO2 (324.2065134)


   

3,5-Dimethyl-3,5-ditert-butyldiphenoquinone

3,5-Dimethyl-3,5-ditert-butyldiphenoquinone

C22H28O2 (324.2089188)


   

Bupivacaine hydrochloride

Bupivacaine hydrochloride

C18H29ClN2O (324.1968294)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents Bupivacaine hydrochloride is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride can be used for the research of chronic pain[1][2][3].

   

(+)-NEOMENTHYLDIPHENYLPHOSPHINE

(+)-NEOMENTHYLDIPHENYLPHOSPHINE

C22H29P (324.2006764)


   

2-(benzylmethylamino)pyridine-5-boronic acid pinacol ester

2-(benzylmethylamino)pyridine-5-boronic acid pinacol ester

C19H25BN2O2 (324.200898)


   
   

4-Ethyl-4-(3,4,5-trifluorophenyl)bi(cyclohexane)

4-Ethyl-4-(3,4,5-trifluorophenyl)bi(cyclohexane)

C20H27F3 (324.2064738)


   

6-(4-Methylbenzylamino)pyridine-3-boronic acid pinacol ester

6-(4-Methylbenzylamino)pyridine-3-boronic acid pinacol ester

C19H25BN2O2 (324.200898)


   

trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methoxy]ethyl]silane

trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methoxy]ethyl]silane

C15H29BN2O3Si (324.2040394)


   

sodium 1-(carboxymethyl)-4,5-dihydro-1(or 3)-(2-hydroxyethyl)-2-nonyl-1H-imidazolium hydroxide

sodium 1-(carboxymethyl)-4,5-dihydro-1(or 3)-(2-hydroxyethyl)-2-nonyl-1H-imidazolium hydroxide

C15H29N2NaO4 (324.20249140000004)


   

3-3-Dimethyl-5-5-ditert-butyl-diphenoquinone

3-3-Dimethyl-5-5-ditert-butyl-diphenoquinone

C22H28O2 (324.2089188)


   

1,2-Ethanediol - 1,1-methylenebis(4-isocyanatocyclohexane) (1:1)

1,2-Ethanediol - 1,1-methylenebis(4-isocyanatocyclohexane) (1:1)

C17H28N2O4 (324.20489680000003)


   

Levobupivacaine hydrochloride

Levobupivacaine hydrochloride

C18H29ClN2O (324.1968294)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE

C15H29BN2O3Si (324.2040394)


   

2-tridecoxyethyl dihydrogen phosphate

2-tridecoxyethyl dihydrogen phosphate

C15H33O5P (324.2065498)


   

Antibiotic 1233A

Antibiotic 1233A

C18H28O5 (324.1936638)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

   

4-Diphenylacetoxy-1,1-dimethylpiperidinium

4-Diphenylacetoxy-1,1-dimethylpiperidinium

C21H26NO2+ (324.19634360000003)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

(R)-(+)-Bupivacaine Hydrochloride

(R)-(+)-Bupivacaine Hydrochloride

C18H29ClN2O (324.1968294)


   

N-[2-(4-morpholinyl)ethyl]-6,7-dihydro-5H-benzo[2,3]cyclohepta[2,4-d]pyridazin-3-amine

N-[2-(4-morpholinyl)ethyl]-6,7-dihydro-5H-benzo[2,3]cyclohepta[2,4-d]pyridazin-3-amine

C19H24N4O (324.19500139999997)


   

Methyl 7-{4-[2-(2-hydroxyethoxy)ethoxy]phenyl}heptanoate

Methyl 7-{4-[2-(2-hydroxyethoxy)ethoxy]phenyl}heptanoate

C18H28O5 (324.1936638)


   

4-Hydroxy-6-(8-hydroxy-2-oxotridecyl)pyran-2-one

4-Hydroxy-6-(8-hydroxy-2-oxotridecyl)pyran-2-one

C18H28O5 (324.1936638)


   

1-(4-Benzylpiperazin-1-yl)-2-(pyridin-2-ylamino)propan-1-one

1-(4-Benzylpiperazin-1-yl)-2-(pyridin-2-ylamino)propan-1-one

C19H24N4O (324.19500139999997)


   

N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide

C17H28N2O4 (324.20489680000003)


   

(3R,5R)-7-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

(3R,5R)-7-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

C18H28O5 (324.1936638)


   

2-[(1R,3S,8R,11S,13R,14S)-14-[(Z)-prop-1-enoxy]-2,7,12-trioxatricyclo[9.5.0.03,8]hexadecan-13-yl]acetaldehyde

2-[(1R,3S,8R,11S,13R,14S)-14-[(Z)-prop-1-enoxy]-2,7,12-trioxatricyclo[9.5.0.03,8]hexadecan-13-yl]acetaldehyde

C18H28O5 (324.1936638)


   

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid

C18H28O5 (324.1936638)


   

2,3-dinor-prostaglandin E2

2,3-dinor-prostaglandin E2

C18H28O5 (324.1936638)


A prostanoid that is prostaglandin E2 lacking two methylenes in the carboxyalkyl chain.

   

DG(15:3)

DG(4:0_11:3)

C18H28O5 (324.1936638)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved